Weixinkang’s subsidiary gets production qualification of Potassium Magnesium Aspartate Injection

On 4 January, Tibet Weixinkang Pharmaceutical Co., Ltd. (Weixinkang; 603676) announced that its wholly-owned subsidiary, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. (Baiyi Pharmaceutical), had obtained the drug registration approval document of Pot...

Amino Acids China E-News 202002

www.cnchemicals.com